Lineage Cell Therapeutics
LCTX
LCTX
102 hedge funds and large institutions have $142M invested in Lineage Cell Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 10 closing their positions.
Holders
102
Holders Change
+13
Holders Change %
+14.61%
% of All Funds
1.8%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
25
Increased
28
Reduced
18
Closed
10
Calls
$400K
Puts
$588K
Net Calls
-$188K
Net Calls Change
-$1.56M
Top Buyers
1 |
1
Two Sigma Advisers
New York
|
$3.84M |
2 |
2
Millennium Management
New York
|
$3.35M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$2.35M |
4 |
4
BlackRock
New York
|
$5.79M |
5 |
5
Two Sigma Investments
New York
|
$2.95M |